Dengue may provide some level of immunity against Covid-19: Study

The not yet published study led by a professor at Duke University, compared the geographic distribution of coronavirus cases with the spread of dengue in 2019 and 2020

Coronavirus, deals, m&a, contracts, tax, MNCs, initiatives, projects
Places with lower coronavirus infection rates and slower case growth were locations that had suffered intense dengue outbreaks this year or last, Nicolelis found
Reuters
3 min read Last Updated : Sep 22 2020 | 2:03 AM IST
A new study that analysed the coronavirus outbreak in Brazil has found a link between the spread of the virus and past outbreaks of dengue fever that suggests exposure to the mosquito-transmitted illness may provide some level of immunity against Covid-19.

The not yet published study led by Miguel Nicolelis, a professor at Duke University, and shared exclusively with Reuters, compared the geographic distribution of coronavirus cases with the spread of dengue in 2019 and 2020.

Places with lower coronavirus infection rates and slower case growth were locations that had suffered intense dengue outbreaks this year or last, Nicolelis found.

"This striking finding raises the intriguing possibility of an immunological cross-reactivity between dengue's Flavivirus serotypes and SARS-CoV-2," the study said, referring to dengue virus antibodies and the novel coronavirus.

"If proven correct, this hypothesis could mean that dengue infection or immunisation with an efficacious and safe dengue vaccine could produce some level of immunological protection" against the coronavirus, it added.

Nicolelis told Reuters the results are particularly interesting because previous studies have shown that people with dengue antibodies in their blood can test falsely positive for Covid-19 antibodies even if they have never been infected by the coronavirus.

"This indicates that there is an immunological interaction between two viruses that nobody could have expected, because the two viruses are from completely different families," Nicolelis said, adding that further studies are needed to prove the connection.

The study was being published ahead of peer review on the MedRxiv preprint server and will be submitted to a scientific journal.

It highlights a significant correlation between lower incidence, mortality and growth rate of Covid-19 in populations in Brazil where the levels of antibodies to dengue were higher.

Brazil has the world's third highest total of Covid-19 infections with more than 4.4 million cases - behind only the United States and India.

In states such as Parana, Santa Catarina, Rio Grande do Sul, Mato Grosso do Sul and Minas Gerais, with a high incidence of dengue last year and early this year, Covid-19 took much longer to reach a level of high community transmission compared to states such as Amapá, Maranhão and Pará that had fewer dengue cases.

The team found a similar relationship between dengue outbreaks and a slower spread of Covid-19 in other parts of Latin America, as well as Asia and islands in the Pacific and Indian Oceans.

Nicolelis said his team came across the dengue discovery by accident, during a study focused on how Covid-19 had spread through Brazil, in which they found that highways played a major role in the distribution of cases across the country.

After identifying certain case-free spots on the map, the team went in search of possible explanations. A breakthrough came when the team compared the spread of dengue with that of the coronavirus.

"It was a shock. It was a total accident," Nicolelis said.

"In science, that happens, you're shooting at one thing and you hit a target that you never imagined you would hit."

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusDengueBrazil

Next Story